Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
national top stories
new york blog main
20
×
boston blog main
life sciences
boston top stories
new york top stories
san francisco blog main
biotech
san diego blog main
san diego top stories
san francisco top stories
fda
detroit blog main
detroit top stories
national
raleigh-durham blog main
wisconsin blog main
boulder/denver blog main
boulder/denver top stories
raleigh-durham top stories
seattle blog main
seattle top stories
texas top stories
wisconsin top stories
clinical trials
indiana blog main
indiana top stories
texas blog main
boston
cancer
drugs
precision medicine
akcea therapeutics
alnylam pharmaceuticals
bristol-myers squibb
foundation medicine
hereditary transthyretin amyloidosis
inotersen
merck
What
medicine
20
×
drug
fda
new
approved
cancer
alnylam
big
bio
making
patients
precision
roundup
week
announced
cells
ceo
depression
disease
gain
gene
genetic
goes
help
known
latest
long
market
medicines
momentum
nobel
oks
post
prize
rna
rnai
series
specifically
study
time
Language
unset
Current search:
medicine
×
" new york blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Ireland to Sequence 400K Genomes With New Precision Medicine Effort
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?